You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 19, 2025

Drug Price Trends for NDC 63481-0629


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 63481-0629

Drug NameNDCPrice/Unit ($)UnitDate
PERCOCET 10-325 MG TABLET 63481-0629-70 39.67937 EACH 2025-01-01
PERCOCET 10-325 MG TABLET 63481-0629-70 36.10497 EACH 2024-12-18
PERCOCET 10-325 MG TABLET 63481-0629-70 36.12408 EACH 2024-11-20
PERCOCET 10-325 MG TABLET 63481-0629-70 36.13678 EACH 2024-10-23
PERCOCET 10-325 MG TABLET 63481-0629-70 36.14078 EACH 2024-09-18
PERCOCET 10-325 MG TABLET 63481-0629-70 36.15094 EACH 2024-08-21
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 63481-0629

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 63481-0629

Introduction

The National Drug Code (NDC) 63481-0629 corresponds to a specific formulation of the drug Percocet, which is a combination of oxycodone hydrochloride and acetaminophen, used for the management of severe pain. Here, we will delve into the market analysis and price projections for this drug, considering various factors that influence its pricing and market dynamics.

Drug Overview

Percocet, with the NDC 63481-0629, is manufactured by Endo USA, Inc. and is classified as a Human Prescription Drug under the DEA Schedule CII. It is an opioid analgesic indicated for pain management when alternative treatments are inadequate[4].

Market Dynamics

Prescription Drug Price Transparency

The pricing of Percocet, like other prescription drugs, is subject to various regulatory and transparency measures. For instance, the Oregon Drug Price Transparency Program requires pharmaceutical manufacturers to report new prescription drugs costing more than $670 a month and annual price increases exceeding 10% for drugs costing more than $100 a month[5].

Historical Price Trends

Historical data shows significant variability in prescription drug prices. For example, the Oregon Drug Price Transparency Program reported that the median price increase for generic drugs was 19.9%, while for brand-name drugs it was 13.4% in 2022. Extreme cases, such as a generic naproxen manufactured by Hikma Pharmaceuticals, saw a 2,527% price increase between 2012 and 2021[2].

Factors Influencing Price

Several factors contribute to the pricing of Percocet:

  • Research and Development Costs: Manufacturers often attribute price increases to the high costs associated with research and development[5].
  • Market Competition: The number of competitors in the market can significantly impact the pricing strategy. With fewer competitors, manufacturers may set higher prices[5].
  • Rebates and Co-pay Assistance Programs: These programs can influence the net price of the drug to consumers and insurers[5].
  • Regulatory Oversight: State and federal regulations, such as those implemented by the Oregon Department of Consumer and Business Services, can affect pricing transparency and accountability[5].

Price Projections

Current Pricing

As of recent reports, the pricing of opioid analgesics like Percocet can be quite high. For instance, the Wholesale Acquisition Cost (WAC) for similar opioid medications has seen significant increases over the years. However, specific current pricing for NDC 63481-0629 would need to be checked through current market data or the FDA's NDC Directory[1].

Future Price Trends

Given the historical trends and factors influencing drug prices:

  • Price Increases: It is likely that Percocet will experience price increases, potentially in the range of 10% to 20% annually, aligning with median increases reported by transparency programs[5].
  • Regulatory Impact: Increased regulatory oversight and transparency measures may help stabilize or reduce price increases. For example, the implementation of upper payment limits or price negotiation authorities could cap excessive price hikes[2].

Comparative Pricing

U.S. prices for prescription drugs, including Percocet, are often significantly higher than those in other countries. This disparity could lead to policy changes aimed at reducing domestic prices. For instance, if the median global price for a cardiovascular drug is between $5 to $164, while the U.S. price is $580, similar disparities might exist for opioid analgesics[5].

Market Competition and Demand

Market Share

Percocet, as a brand-name drug, holds a significant market share in the opioid analgesic segment. However, the presence of generic alternatives can impact its market share and pricing strategy.

Demand Factors

The demand for opioid analgesics is influenced by several factors, including:

  • Clinical Need: The ongoing need for effective pain management ensures a steady demand for drugs like Percocet.
  • Regulatory Environment: Changes in regulations, such as stricter prescribing guidelines for opioids, can affect demand and subsequently impact pricing[4].

Conclusion

The market analysis and price projections for Percocet with the NDC 63481-0629 indicate that the drug is likely to experience continued price increases, albeit potentially mitigated by regulatory measures. Here are some key takeaways:

Key Takeaways

  • Price Increases: Annual price increases in the range of 10% to 20% are plausible.
  • Regulatory Impact: Increased transparency and regulatory oversight could stabilize or reduce price hikes.
  • Comparative Pricing: U.S. prices are significantly higher than global prices, which may lead to policy changes.
  • Market Competition: The presence of generic alternatives and regulatory changes can impact market share and pricing.

FAQs

What is the NDC code for Percocet?

The NDC code for a specific formulation of Percocet is 63481-0629.

Who manufactures Percocet with the NDC 63481-0629?

Percocet with the NDC 63481-0629 is manufactured by Endo USA, Inc.[4].

What factors influence the pricing of Percocet?

Factors include research and development costs, market competition, rebates, co-pay assistance programs, and regulatory oversight[5].

How does the Oregon Drug Price Transparency Program affect drug pricing?

The program requires manufacturers to report price increases and new high-cost drugs, providing transparency and accountability in drug pricing[5].

Are there any regulatory measures to cap excessive price hikes for prescription drugs?

Yes, measures such as upper payment limits and price negotiation authorities are being considered or implemented in various states and at the federal level[2].

How does the global pricing of prescription drugs compare to U.S. prices?

U.S. prices for prescription drugs are often significantly higher than global prices, with U.S. prices sometimes being five times higher than the highest global price[5].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services
  3. Draft Prescription Drug (RXCUIs) to HHS Drug Classes (RXCs) - CMS
  4. Label: Percocet- oxycodone hydrochloride and acetaminophen tablet - DailyMed
  5. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services (2019)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.